#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10364	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	515.7	0	.	n	.	0	C451T	SNP	451	451	C	682	682	T	566	T,C	285,276	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10364	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	515.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	586	C	580	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10364	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	515.7	0	HET	.	.	.	G421A,T	.	421	421	G	652	652	G	592	G,A,T	468,115,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10364	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1976	515.7	0	HET	.	.	.	C207T,G	.	207	207	C	438	438	C	612	C,T,G	468,125,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	0	.	n	.	0	T695C	SNP	695	695	T	1019	1019	C	549	C	538	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2295	2295	C	605	C	589	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2369	2369	A	600	A	586	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2921	2921	C	567	C	555	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1962	1962	A	599	A,G	443,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	18802	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3526	530.6	0	HET	.	.	.	C1811T	.	1811	1811	C	2135	2135	C	587	C,T	303,274	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1348	folP	855	855	100.0	folP.l15.c4.ctg.1	1479	90.5	1	SNP	p	R229S	1	.	.	685	687	AGC	989	991	AGC	133;134;137	A;G,A;C	131;131,1;134	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3515	111.7	1	SNP	p	S91F	1	.	.	271	273	TTC	635	637	TTC	149;146;151	T,A;T,C;C	146,1;143,2;148	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3515	111.7	1	SNP	p	G95N	0	.	.	283	285	GGC	647	649	GGC	158;159;160	G;G,A;C	155;154,2;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3940	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3515	111.7	1	SNP	p	D95G	1	.	.	283	285	GGC	647	649	GGC	158;159;160	G;G,A;C	155;154,2;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1162	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1214	94.7	1	SNP	p	G45D	0	.	.	133	135	GGC	413	415	GGC	148;146;146	G;G,T;C,G	141;138,1;139,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	572	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1167	48.8	0	.	n	.	0	A197.	DEL	197	197	A	611	611	A	124	A	123	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3540	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	121.9	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	124;122;122	G;A,C;C	122;114,1;119	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3540	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	121.9	1	SNP	p	R87W	0	.	.	259	261	CGT	538	540	CGT	121;120;121	C;G;T	119;116;114	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3540	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	121.9	1	SNP	p	R87I	0	.	.	259	261	CGT	538	540	CGT	121;120;121	C;G;T	119;116;114	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3540	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	121.9	1	SNP	p	S87R	1	.	.	259	261	CGT	538	540	CGT	121;120;121	C;G;T	119;116;114	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3540	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	121.9	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	121;121;120	T;C;C	117;121;120	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2998	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2484	119.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1452	1454	GGC	133;131;132	G;G;C	127;124;124	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1224	1226	GCC	156;156;158	G;C;C	154;154;155	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1227	1229	ATG	158;157;156	A;T;G,T	155;152;152,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1239	1241	ACC	150;152;153	A;C;C	144;147;147	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1239	1241	ACC	150;152;153	A;C;C	144;147;147	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1740	1742	ACC	146;147;145	A;C;C	134;142;142	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1794	1796	GCG	140;136;134	G;C;G	139;135;133	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1794	1796	GCG	140;136;134	G;C;G	139;135;133	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1917	1919	GGT	111;111;110	G;G,C;T	107;106,1;105	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1926	1928	AGC	103;99;98	A;G;C	96;98;93	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2710	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2270	117.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1944	1946	CCG	86;87;84	C,G;C;G	80,4;79;75	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3968	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3048	129.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1592	1594	CCG	161;158;158	C;C,T;G,A	149;149,2;147,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1774	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1720	102.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	116	C	104	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1958	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1588	122.0	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	429	431	CAG	140;141;139	C;A,G;G	138;139,1;137	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1958	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1588	122.0	1	SNP	p	G120K	1	.	.	358	360	AAG	669	671	AAG	135;133;135	A;A;G	131;131;127	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1958	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1588	122.0	1	SNP	p	A121N	1	.	.	361	363	AAC	672	674	AAC	136;137;138	A;A;C	133;136;135	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1958	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1588	122.0	1	SNP	p	N121D	0	.	.	361	363	AAC	672	674	AAC	136;137;138	A;A;C	133;136;135	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6894	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4769	143.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	900	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1010	88.6	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	174;174;173	A,G;T;G,C	171,1;171;170,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
